Tag Archives: Zofran lawyer

Plaintiffs Oppose GlaxoSmithKline’s Motion to Dismiss Failure to Warn Claims

With already more than 200 complaints pending in the Zofran (ondansetron) federal multidistrict litigation (“MDL”) in the District of Massachusetts, the drug’s manufacturer GlaxoSmithKline (“GSK”) is asking U.S. District Judge Dennis Saylor to dismiss the plaintiffs’ failure-to-warn claims, arguing there is evidence that the FDA would have rejected any warning label update the plaintiffs claim …. Read More

Comments Off on Plaintiffs Oppose GlaxoSmithKline’s Motion to Dismiss Failure to Warn Claims

Grant & Eisenhofer’s Beth Graham One of Three Selected to Lead Zofran (ondansetron) MDL

After more than 100 cases over GlaxoSmithKline’s “off label” marketing of its anti-nausea drug Zofran (ondansetron) were centralized under one umbrella in a multidistrict litigation (“MDL”), Massachusetts district Judge Dennis Saylor presiding over the litigation has selected three pharmaceutical mass tort attorneys to lead the litigation. Grant & Eisenhofer Director Beth Graham was appointed as …. Read More

Comments Off on Grant & Eisenhofer’s Beth Graham One of Three Selected to Lead Zofran (ondansetron) MDL

New Study Finds Off-Label Prescription Drug Use Increases Likelihood of Adverse Events

A new study out of the Journal of the American Medical Association has shed some light on a longtime concern of the FDA that taking prescription drugs for uses unapproved by the regulatory agency may do more harm than good.  In fact, researchers from McGill University in Montreal, Harvard Medical School, and MCPHS University who led …. Read More

Comments Off on New Study Finds Off-Label Prescription Drug Use Increases Likelihood of Adverse Events

Zofran (ondansetron) MDL Transferred to Massachusetts

In an anticipated decision by the Judicial Panel on Multidistrict Litigation (“Panel”) regarding the consolidation of  Zofran (ondansetron) litigation, on October 13, 2015, the Panel ordered that cases pending in several federal district courts to will be consolidated and transferred to the District of Massachusetts before Judge F. Dennis Saylor, IV.  More than 50 Zofran cases …. Read More

Comments Off on Zofran (ondansetron) MDL Transferred to Massachusetts

Grant & Eisenhofer’s Beth Graham to Speak on Zofran (ondansetron) and the Progressing Litigation on Behalf of Children and Families

On October 15, 2015, Beth Graham, Director at plaintiffs’ law firm Grant & Eisenhofer, will present updates on the Zofran (ondansetron) litigation. Grant & Eisenhofer has been at the forefront of the litigation, filing the first case and several others thereafter representing plaintiffs alleging that the anti-nausea drug manufactured by GlaxoSmithKline caused birth defects such …. Read More

Comments Off on Grant & Eisenhofer’s Beth Graham to Speak on Zofran (ondansetron) and the Progressing Litigation on Behalf of Children and Families
Contact Us
Web Analytics